| Autor: |
Chapman, MJ, Ginsberg, HN, Amarenco, P, Andreotti, F, Borén, J, Catapano, AL, Descamps, OS, Fisher, E, Kovanen, PT, Kuivenhoven, JA, Lesnik, P, Masana, L, Nordestgaard, BG, Ray, KK, Reiner, Z, Taskinen, MR, Tokgözoglu, L, Tybjærg-Hansen, A, Watts, GF, European Atherosclerosis Society Consensus Panel |
| Jazyk: |
angličtina |
| Rok vydání: |
2011 |
| Předmět: |
|
| ISSN: |
0195-668X |
| Popis: |
Even at low-density lipoprotein cholesterol (LDL-C) goal, patients with cardiometabolic abnormalities remain at high risk of cardiovascular events. This paper aims (i) to critically appraise evidence for elevated levels of triglyceride-rich lipoproteins (TRLs) and low levels of high-density lipoprotein cholesterol (HDL-C) as cardiovascular risk factors, and (ii) to advise on therapeutic strategies for management. Current evidence supports a causal association between elevated TRL and their remnants, low HDL-C, and cardiovascular risk. This interpretation is based on mechanistic and genetic studies for TRL and remnants, together with the epidemiological data suggestive of the association for circulating triglycerides and cardiovascular disease. For HDL, epidemiological, mechanistic, and clinical intervention data are consistent with the view that low HDL-C contributes to elevated cardiovascular risk; genetic evidence is unclear however, potentially reflecting the complexity of HDL metabolism. The Panel believes that therapeutic targeting of elevated triglycerides (≥1.7 mmol/L or 150 mg/dL), a marker of TRL and their remnants, and/or low HDL-C ( |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
